Document Basket

Saved pages

Saved documents

Please note: This information is saved in a cookie. In case your browser deletes cookies after a session, the information will be lost.

DKSH brings Cyrcadia Asia’s innovation in breast cancer screening to Hong Kong January 21, 2019


			
				DKSH brings Cyrcadia Asia’s innovation in breast cancer screening to Hong Kong

DKSH, the leading Market Expansion Services provider with a focus on Asia, and Cyrcadia Asia, a Hong Kong medical device company, have partnered to bring Cyrcadia’s application of artificial intelligence for breast cancer screening to Hong Kong.

Media release

DKSH brings Cyrcadia Asia’s innovation in breast cancer screening to Hong Kong

DKSH, the leading Market Expansion Services provider with a focus on Asia, and Cyrcadia Asia, a Hong Kong medical device company, have partnered to bring Cyrcadia’s application of artificial intelligence for breast cancer screening to Hong Kong.

Hong Kong, January 21, 2019 – DKSH Hong Kong, the leading Market Expansion Services provider for companies seeking to grow their business, has started its partnership with Cyrcadia Asia. The Hong Kong-based company has developed a smart bra insert that detects the early signs of breast cancer. DKSH is driving education in medical channels through its strong sales workforce and will soon roll-out this medical device to the over-the counter markets in a one-stop-shop model for both Hong Kong and Macau.

 

Cyrcadia’s technology consists of a comfortable set of patches that, when worn during a woman’s normal daily or nightly activity, will automatically monitor her breast health. Worn as a personal, intelligent monthly breast health monitor, Cyrcadia uses dynamic thermal analysis, not radiation or compression, to measure personal circadian temperature patterns, including those that relate to cancer. Automated results are sent through the woman’s own phone to an intelligent database, which returns results in minutes to the woman and even to her physician, if requested. This revolutionary product shifts the landscape from late-stage clinical diagnosis to early detection with a personal wearable device.

 

“Working with clients to bring innovation to patients’ lives is always our priority. Having the possibility to perform medical checks at one’s fingertips, while going about your daily business in fast-paced Hong Kong is truly game-changing and, at the same time, brings peace of mind to patients,” commented Grace Lau, Head, Management, Hong Kong, DKSH Hong Kong. “We see huge business potential for Cyrcadia Asia and we are dedicated to supporting Hong Kong companies to expand their innovative healthcare solutions in and beyond Hong Kong.”

 

“We are impressed by the comprehensive network offered by DKSH and the professionalism of its Healthcare team. DKSH has accurately met our needs as a market pioneer in early breast cancer screening. It outpaced other competitors in the market, by addressing our critical go-to-market requirements and paid great attention to our needs,” said Rob Royea, Chief Executive Officer, Cyrcadia Asia. “We are looking forward to a fruitful partnership with DKSH and a potential expanded relationship throughout Asia.”